Literature DB >> 27465652

Atrial fibrillation: Stroke prevention in atrial fibrillation: can we do better?

Deirdre A Lane1, Gregory Y H Lip1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27465652     DOI： 10.1038/nrcardio.2016.117

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation.

Authors:  D A Lane; G Y H Lip
Journal:  Thromb Haemost       Date:  2014-01-30       Impact factor: 5.249

2.  National Trends in Ambulatory Oral Anticoagulant Use.

Authors:  Geoffrey D Barnes; Eleanor Lucas; G Caleb Alexander; Zachary D Goldberger
Journal:  Am J Med       Date:  2015-07-02       Impact factor: 4.965

3.  Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?

Authors:  Laurent Fauchier; Nicolas Clementy; Arnaud Bisson; Fabrice Ivanes; Denis Angoulvant; Dominique Babuty; Gregory Y H Lip
Journal:  Stroke       Date:  2016-05-26       Impact factor: 7.914

4.  Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.

Authors:  Joshua Buck; Peter Kaboli; Brian F Gage; Peter Cram; Mary S Vaughan Sarrazin
Journal:  Am Heart J       Date:  2016-06-21       Impact factor: 4.749

Review 5.  The role of aspirin for stroke prevention in atrial fibrillation.

Authors:  Gregory Y H Lip
Journal:  Nat Rev Cardiol       Date:  2011-07-26       Impact factor: 32.419

6.  Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy.

Authors:  Gregory Y H Lip; Flemming Skjøth; Peter B Nielsen; Torben Bjerregaard Larsen
Journal:  Thromb Haemost       Date:  2015-07-30       Impact factor: 5.249

7.  Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Authors:  Michael W Cullen; Sunghee Kim; Jonathan P Piccini; Jack E Ansell; Greg C Fonarow; Elaine M Hylek; Daniel E Singer; Kenneth W Mahaffey; Peter R Kowey; Laine Thomas; Alan S Go; Renato D Lopes; Paul Chang; Eric D Peterson; Bernard J Gersh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-06-11

8.  Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.

Authors:  Jonathan C Hsu; Thomas M Maddox; Kevin Kennedy; David F Katz; Lucas N Marzec; Steven A Lubitz; Anil K Gehi; Mintu P Turakhia; Gregory M Marcus
Journal:  J Am Coll Cardiol       Date:  2016-06-28       Impact factor: 24.094

9.  Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.

Authors:  Ajay K Kakkar; Iris Mueller; Jean-Pierre Bassand; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke; Gregory Y H Lip; Lorenzo G Mantovani; Alexander G G Turpie; Martin van Eickels; Frank Misselwitz; Sophie Rushton-Smith; Gloria Kayani; Peter Wilkinson; Freek W A Verheugt
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study.

Authors:  Peter Brønnum Nielsen; Torben Bjerregaard Larsen; Flemming Skjøth; Thure Filskov Overvad; Gregory Y H Lip
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379
  10 in total
  1 in total

Review 1.  Photoplethysmography based atrial fibrillation detection: a review.

Authors:  Tania Pereira; Nate Tran; Kais Gadhoumi; Michele M Pelter; Duc H Do; Randall J Lee; Rene Colorado; Karl Meisel; Xiao Hu
Journal:  NPJ Digit Med       Date:  2020-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.